Celebrex Branded DTC Campaign Launches In 50 Publications
Searle/Pfizer's first branded direct-to-consumer ad campaign for the COX-2 inhibitor Celebrex will run in approximately 50 publications after its Sept. 8 launch.
Searle/Pfizer's first branded direct-to-consumer ad campaign for the COX-2 inhibitor Celebrex will run in approximately 50 publications after its Sept. 8 launch.